Silent Heart Attack Raises Cerebral Infarction Risk
|
By HospiMedica International staff writers Posted on 06 Jun 2019 |
A new study reveals that asymptomatic (silent) heart attacks are associated with double the risk of cardiac embolism and stroke of undetermined cause.
Researchers at Weill Cornell Medical College (New York, NY, USA), the Icelandic Heart Association (IHA; Kopavogur, Iceland), and other institutions conducted a cross-sectional study that included 925 community-dwelling Icelandic individuals (51.9% women, mean age 75.9 years) who underwent both brain magnetic resonance imaging (MRI) and late gadolinium enhanced cardiac MRI to determine whether unrecognized mitral infarction (MI) is associated with cerebral infarction. The main outcomes and measures were unrecognized MI, defined as cardiac MRI evidence of MI without a history of clinical evidence.
The results revealed that 23.9% of participants had cardiac MRI evidence of a heart attack. Of these, 67 experienced MI with symptoms, while 153 had silent heart attack. Overall, 33% had brain MRI evidence of a stroke, and 10% had a stroke of undetermined cause. The researchers calculated that people with symptomatic MI were twice as likely to have a stroke, while those with silent heart attack were 1.5 times as likely to have a stroke. Adjusted for demographics and vascular risk factors, unrecognized MI was also associated with embolic infarcts of undetermined source. The study was published on May 20, 2019, in JAMA Neurology.
“Silent heart attack may be a risk factor for stroke, and may explain some proportion of stroke of undetermined cause; the clot formation that occurs with symptomatic heart attack may also occur with silent heart attack,” said lead study author neurologist Alexander Merkler, MD, of Weill Cornell Medical College. “If further studies confirm these results, doctors may more readily use cardiac MRI in patients with stroke of undetermined cause to see whether there is evidence of silent heart attack. They may also want to compare the effectiveness of anticoagulants to antiplatelet medications such as aspirin, which prevent platelets from clumping together.”
More than 700,000 people a year in the United States alone are diagnosed with a stroke, but in 20-25% of these patients, the cause of stroke cannot be determined. One possible explanation for these strokes is that a distant blood clot travels to the brain following a heart attack. About 50% of all heart attack patients do not experience any symptoms.
Related Links:
Weill Cornell Medical College
Icelandic Heart Association
Researchers at Weill Cornell Medical College (New York, NY, USA), the Icelandic Heart Association (IHA; Kopavogur, Iceland), and other institutions conducted a cross-sectional study that included 925 community-dwelling Icelandic individuals (51.9% women, mean age 75.9 years) who underwent both brain magnetic resonance imaging (MRI) and late gadolinium enhanced cardiac MRI to determine whether unrecognized mitral infarction (MI) is associated with cerebral infarction. The main outcomes and measures were unrecognized MI, defined as cardiac MRI evidence of MI without a history of clinical evidence.
The results revealed that 23.9% of participants had cardiac MRI evidence of a heart attack. Of these, 67 experienced MI with symptoms, while 153 had silent heart attack. Overall, 33% had brain MRI evidence of a stroke, and 10% had a stroke of undetermined cause. The researchers calculated that people with symptomatic MI were twice as likely to have a stroke, while those with silent heart attack were 1.5 times as likely to have a stroke. Adjusted for demographics and vascular risk factors, unrecognized MI was also associated with embolic infarcts of undetermined source. The study was published on May 20, 2019, in JAMA Neurology.
“Silent heart attack may be a risk factor for stroke, and may explain some proportion of stroke of undetermined cause; the clot formation that occurs with symptomatic heart attack may also occur with silent heart attack,” said lead study author neurologist Alexander Merkler, MD, of Weill Cornell Medical College. “If further studies confirm these results, doctors may more readily use cardiac MRI in patients with stroke of undetermined cause to see whether there is evidence of silent heart attack. They may also want to compare the effectiveness of anticoagulants to antiplatelet medications such as aspirin, which prevent platelets from clumping together.”
More than 700,000 people a year in the United States alone are diagnosed with a stroke, but in 20-25% of these patients, the cause of stroke cannot be determined. One possible explanation for these strokes is that a distant blood clot travels to the brain following a heart attack. About 50% of all heart attack patients do not experience any symptoms.
Related Links:
Weill Cornell Medical College
Icelandic Heart Association
Latest Critical Care News
- AI Tool Predicts Bronchopulmonary Dysplasia Risk in Preterm Infants
- Optical Brain Monitoring Predicts Neurodevelopmental Outcomes in Preterm Infants
- AI Tool Identifies Children With Pneumonia Requiring Hospital Care
- AI Ultrasound System Improves Safety of Blood–Brain Barrier Opening
- CE-Marked Smartphone AI Enables Autonomous Skin Cancer Assessment at Point of Care
- Handheld Optical Device Screens for Early Necrotizing Enterocolitis in Preterm Infants
- Home Blood Pressure Telemonitoring Linked to Fewer Cardiovascular Events
- Tiny Wearable Patch Tracks Heart and Respiratory Changes at Home
- Smartphone Heart Rhythm App Reduces Unnecessary Cardioversion Procedures
- AI-Guided Mammogram Triage Speeds Same-Day Breast Cancer Workup
- Handheld ECG Algorithm Shows Promise for At-Home Heart Attack Risk Assessment
- Bedside CSF Monitor Detects Early Infection in Fluid Drains
- Wearable Ultrasound Patch Noninvasively Paces Heart to Stabilize Arrhythmias
- New Practice Guidance Supports Prostatic Artery Embolization for BPH Symptoms
- AI ECG Tool Detects Cardiac Amyloidosis for Early Screening
- Cuffless Wearable Enables Continuous Blood Pressure Monitoring for Hypertension Care
Channels
Artificial Intelligence
view channel
New AI ECG Tool Detects Early Heart Disease
Heart disease remains a leading cause of premature death, claiming almost 18 million lives each year. Early detection is crucial because timely intervention can change prognosis and conserve resources.... Read more
AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure
Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read moreSurgical Techniques
view channel
Automated EMR-Based Tool Detects Immune-Related Colitis in Immunotherapy Patients
Immune-related colitis is inflammation of the bowel triggered by cancer immunotherapy with immune checkpoint inhibitors. The condition is common and can be serious, disrupting treatment plans and driving... Read more
Personalized Cartilage Graft Offers New Option for Infants with Severe Airway Narrowing
Severe subglottic stenosis is a narrowing of the airway below the vocal cords and above the trachea. The condition can leave infants dependent on tracheostomy while awaiting reconstructive surgery to enable... Read morePatient Care
view channel
AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
Radiation oncology consultations require patients to grasp complex concepts quickly, yet anxiety and information overload often undermine understanding and informed consent. Poor comprehension can also... Read more
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read moreHealth IT
view channel
Digital Heart Model Supports Targeted Ablation in Atrial Fibrillation
Atrial fibrillation is an erratic, quivering heartbeat and a leading cause of stroke. Catheter ablation is widely used to interrupt arrhythmogenic tissue, yet many patients—especially with persistent ... Read moreAI Framework Helps Clinicians Create Trustworthy Risk Prediction Tools
Artificial intelligence (AI) is increasingly used to estimate risks for conditions such as sepsis, heart disease, and cancer, yet many models remain difficult for clinicians to interpret or trust.... Read morePoint of Care
view channel
Handheld AI Device for Point-of-Care Skin Lesion Assessment Receives CE Mark
DermaSensor (Miami, FL, USA) has received a Class IIb CE Mark for its handheld DermaSensor device, marking the start of the company’s global expansion strategy. The certification demonstrates conformity... Read more
Portable Immunoassay System Advances Toward Point-of-Care Biomarker Testing
Proxim Diagnostics Corp. (Santa Clara, CA, USA) has announced that its Profile System, a handheld point-of-care immunoassay platform, has completed development. The milestone includes completion... Read more
Portable MRI System Accelerates Emergency Brain Imaging and Triage
Emergency departments frequently face delays accessing conventional magnetic resonance imaging (MRI) for patients with suspected neurological emergencies. Such waits can slow triage, prolong boarding,... Read more







